Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet (2022) 400(10369):2221–48. https://doi.org/10.1016/s0140-6736(22)02185-7
Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Infect Dis (2024) 24(9):974–1002. https://doi.org/10.1016/s1473-3099(24)00176-2.
Ahmad-Mansour N, Loubet P, Pouget C, Dunyach-Remy C, Sotto A, Lavigne JP et al (2021) Staphylococcus aureus toxins: an update on their pathogenic properties and potential treatments. Toxins (Basel) 13(10):677. https://doi.org/10.3390/toxins13100677
Article PubMed CAS Google Scholar
Vestergaard M, Frees D, Ingmer H (2019) Antibiotic resistance and the MRSA problem. Microbiol Spectr 7(2). https://doi.org/10.1128/microbiolspec.GPP3-0057-2018
McGuinness WA, Malachowa N, DeLeo FR (2017) Vancomycin resistance in S. aureus. Yale J Biol Med 90(2):269–81
PubMed PubMed Central CAS Google Scholar
de Kraker ME, Stewardson AJ, Harbarth S (2016) Will 10 million people die a year due to antimicrobial resistance by 2050? PLoS Med 13(11):e1002184. https://doi.org/10.1371/journal.pmed.1002184
Article PubMed PubMed Central Google Scholar
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet (2022) 396(10258):1204–22. https://doi.org/10.1016/s0140-6736(20)30925-9
Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the global burden of disease study 2019. Lancet Infect Dis(2022) 22(11):1626–47. https://doi.org/10.1016/s1473-3099(22)00510-2
Hu J, Zhou R, Ding R, Ye DW, Su Y (2023) Effect of PM(2.5) air pollution on the global burden of lower respiratory infections, 1990–2019: a systematic analysis from the global burden of disease study 2019. J Hazard Mater 459:132215. https://doi.org/10.1016/j.jhazmat.2023.132215
Article PubMed CAS Google Scholar
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet (2020) 396(10258):1223–49. https://doi.org/10.1016/s0140-6736(20)30752-2
Safiri S, Mahmoodpoor A, Kolahi AA, Nejadghaderi SA, Sullman MJM, Mansournia MA et al (2022) Global burden of lower respiratory infections during the last three decades. Front Public Health 10:1028525. https://doi.org/10.3389/fpubh.2022.1028525
Rosenberg PS, Anderson WF (2011) Age-period-cohort models in cancer surveillance research: ready for prime time? Cancer Epidemiol Biomarkers Prev 20(7):1263–8. https://doi.org/10.1158/1055-9965.Epi-11-0421
Article PubMed PubMed Central Google Scholar
Bell A (2020) Age period cohort analysis: a review of what we should and shouldn’t do. Ann Hum Biol 47(2):208–217. https://doi.org/10.1080/03014460.2019.1707872
Zou Z, Cini K, Dong B, Ma Y, Ma J, Burgner DP et al (2020) Time trends in cardiovascular disease mortality across the BRICS: an age-period-cohort analysis of key nations with emerging economies using the global burden of disease study 2017. Circulation 141(10):790–799. https://doi.org/10.1161/circulationaha.119.042864
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the global burden of disease study 2021. Lancet (2024)403(10440):2133–61. https://doi.org/10.1016/s0140-6736(24)00757-8
Li Y, Ning Y, Shen B, Shi Y, Song N, Fang Y et al (2023) Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019: an analysis of the global burden of disease study 2019. Clin Kidney J 16(2):312–21. https://doi.org/10.1093/ckj/sfac218
Hosseinpoor AR, Bergen N, Schlotheuber A (2015) Promoting health equity: WHO health inequality monitoring at global and national levels. Glob Health Action 8:29034. https://doi.org/10.3402/gha.v8.29034
Ordunez P, Martinez R, Soliz P, Giraldo G, Mujica OJ, Nordet P (2019) Rheumatic heart disease burden, trends, and inequalities in the Americas, 1990–2017: a population-based study. Lancet Glob Health 7(10):e1388–e1397. https://doi.org/10.1016/s2214-109x(19)30360-2
Gao L, Xia L, Pan SQ, Xiong T, Li SC (2014) Burden of epilepsy: a prevalence-based cost of illness study of direct, indirect and intangible costs for epilepsy. Epilepsy Res 110:146–156. https://doi.org/10.1016/j.eplepsyres.2014.12.001
Li XY, Kong XM, Yang CH, Cheng ZF, Lv JJ, Guo H et al (2021) Global, regional, and national burden of ischemic stroke, 1990–2021: an analysis of data from the global burden of disease study 2021. EClinicalMedicine 75:102758. https://doi.org/10.1016/j.eclinm.2024.102758
Zhang Y, Liu J, Han X, Jiang H, Zhang L, Hu J et al (2022) Long-term trends in the burden of inflammatory bowel disease in China over three decades: a joinpoint regression and age-period-cohort analysis based on GBD 2019. Front Public Health 10:994619. https://doi.org/10.3389/fpubh.2022.994619
Article PubMed PubMed Central Google Scholar
Jin X, Ren J, Li R, Gao Y, Zhang H, Li J et al (2021) Global burden of upper respiratory infections in 204 countries and territories, from 1990 to 2019. EClinicalMedicine 37:100986. https://doi.org/10.1016/j.eclinm.2021.100986
Article PubMed PubMed Central Google Scholar
Safiri S, Kolahi AA, Hoy D, Buchbinder R, Mansournia MA, Bettampadi D et al (2020) Global, regional, and national burden of neck pain in the general population, 1990–2017: systematic analysis of the global burden of disease study 2017. Bmj 368:m791. https://doi.org/10.1136/bmj.m791
Article PubMed PubMed Central Google Scholar
Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990–2019: a systematic analysis from the global burden of disease study 2019. Lancet Glob Health (2022) 10(12):e1715-e43. https://doi.org/10.1016/s2214-109x(22)00429-6.
Laupland KB, Lyytikäinen O, Søgaard M, Kennedy KJ, Knudsen JD, Ostergaard C et al (2013) The changing epidemiology of S. aureus bloodstream infection: a multinational population-based surveillance study. Clin Microbiol Infect 19(5):465–71. https://doi.org/10.1111/j.1469-0691.2012.03903.x
Article PubMed CAS Google Scholar
Nazarenko Y, Pal D, Ariya PA (2021) Air quality standards for the concentration of particulate matter 2.5, global descriptive analysis. Bull World Health Organ 99(2):125–37d. https://doi.org/10.2471/blt.19.245704
Al-Sayyar A, Hulme KD, Thibaut R, Bayry J, Sheedy FJ, Short KR et al (2022) Respiratory tract infections in diabetes - lessons from tuberculosis and influenza to guide understanding of COVID-19 severity. Front Endocrinol (Lausanne) 13:919223. https://doi.org/10.3389/fendo.2022.919223
Kim V, Criner GJ (2013) Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 187(3):228–237. https://doi.org/10.1164/rccm.201210-1843CI
Article PubMed PubMed Central CAS Google Scholar
Nikolich-Žugich J (2018) The twilight of immunity: emerging concepts in aging of the immune system. Nat Immunol 19(1):10–19. https://doi.org/10.1038/s41590-017-0006-x
Article PubMed CAS Google Scholar
Yang C, Xu H, Jia R, Jin Z, Zhang C, Yuan J (2022) Global burden and improvement gap of non-rheumatic calcific aortic valve disease: 1990–2019 findings from global burden of disease study 2019. J Clin Med 11(22):6733. https://doi.org/10.3390/jcm11226733
Article PubMed PubMed Central Google Scholar
Stensen DB, Cañadas RAN, Småbrekke L, Olsen K, Nielsen CS, Svendsen K et al (2022) Social network analysis of S. aureus carriage in a general youth population. Int J Infect Dis 123:200–209. https://doi.org/10.1016/j.ijid.2022.08.018
Liu Q, Deng J, Yan W, Qin C, Du M, Wang Y et al (2024) Burden and trends of infectious disease mortality attributed to air pollution, unsafe water, sanitation, and hygiene, and non-optimal temperature globally and in different socio-demographic index regions. Glob Health Res Policy 9(1):23. https://doi.org/10.1186/s41256-024-00366-x
Article PubMed PubMed Central Google Scholar
Costa D, Rohleder S, Bozorgmehr K (2024) Impact of non-pharmaceutical interventions on COVID-19 incidence and deaths: cross-national natural experiment in 32 European countries. BMC Public Health 24(1):2341. https://doi.org/10.1186/s12889-024-19799-7
Article PubMed PubMed Central Google Scholar
Findling MG, Blendon RJ, Benson JM (2020) Delayed care with harmful health consequences-reported experiences from national surveys during coronavirus disease 2019. JAMA Health Forum 1(12):e201463. https://doi.org/10.1001/jamahealthforum.2020.1463
Adalbert JR, Varshney K, Tobin R, Pajaro R (2021) Clinical outcomes in patients co-infected with COVID-19 and S. aureus: a scoping review. BMC Infect Dis 21(1):985.
Comments (0)